Manufacturer record
SVP Life Sciences: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
15 batches manufactured by SVP Life Sciences (Uttarakhand) were declared Not of Standard Quality between March 2024 and June 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
15 records linked to SVP Life Sciences in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Frusemide Injection IP- 2ml | 24BTH96Mfg 2024-08 · Exp 2026-07 | Assay for frusemideAssay | King Institute ChennaiState lab | Jun 2025 |
| Cyanocobalamin I.P.- Cynoder Injection I.P. (VITAMIN B12 INJ) | AM-362Mfg 2024-10 · Exp 2026-09 | Sterility? and ?Assay for Anhydrous CyanocobalaminAssay | State Lab KarnatakaState lab | Jun 2025 |
| Gentamicin Injection IP-2ML | 24BUH85Mfg 2024-08 · Exp 2026-07 | Sample does not conform to the requirement for pHpH | King Institute of Preventive Medicine & Research, Guindy, Chennai-32State lab | May 2025 |
| Gentamicin Injection I.P- 2ml | 24BUH83Mfg 2024-08 · Exp 2026-07 | Sample does not conform to the requirement for pH.pH | King Institute ChennaiState lab | Apr 2025 |
| Frusemide Injection IP- 2ml | 24BTC63Mfg 2024-03 · Exp 2026-02 | Sample does not conform to requirement for sterilitySterility | King Institute ChennaiState lab | Apr 2025 |
| Gentamicin Injection IP- 2ml | 24BUE74Mfg 2024-05 · Exp 2026-04 | Sample does not conform to the requirement for PH.pH | King Institute ChennaiState lab | Jan 2025 |
| Metoclopramide HCL Injection I.P-2ml | 24DQC64Mfg 2024-03 · Exp 2026-02 | sample does not conform to the requirement for Assay of MetoclopramideAssay | King Institute ChennaiState lab | Dec 2024 |
| Promethazine Injection IP-2ML | 24FNC80Mfg 2024-03 · Exp 2026-02 | Sample does not conform to requirement for assay.Assay | DTL ChennaiState lab | Nov 2024 |
| Dicyclomine Hydrochloride Injection IP-2ML | 23BDK74Mfg 2023-11 · Exp 2025-10 | Sample does not conform to the requirement for AssayAssay | DTL ChennaiState lab | Nov 2024 |
| Atropine Sulphate Injection IP | 23UG18Mfg 2023-07 · Exp 2025-06 | The sample does not conforms to claim as per IP2022in respect to the Test of pH and Assay of Atropine SulphateAssay | RDTL ChandigarhCDSCO lab | May 2024 |
| Metoclopramide Injection IP 10mg / 2ml | 23DQE20Mfg 2023-05 · Exp 2025-04 | AssayAssay | CDL KolkataCDSCO lab | Apr 2024 |
| Atropine Sulphate Injection IP | 23UJ85Mfg 2023-10 · Exp 2025-09 | pH, Particulate Matter & AssayAssay | CDL KolkataCDSCO lab | Apr 2024 |
| Methylcobalamin Injection 1500 mcg / 2 ml (Mithcoll 1500 Injection) | SVL-73Mfg 2023-11 · Exp 2025-04 | Description & Particulate MatterDescription | CDL KolkataCDSCO lab | Mar 2024 |
| Gentamicin Injection IP 40 mg | 23BUI59Mfg 2023-09 · Exp 2025-08 | Particulate Matter, pH & AssayAssay | CDL KolkataCDSCO lab | Mar 2024 |
| Dicyclomine Hydrochloride Injection I.P. 10 mg | RM-46Mfg 2023-02 · Exp 2025-01 | Description & Particulate MatterDescription | CDL KolkataCDSCO lab | Mar 2024 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.